108 related articles for article (PubMed ID: 1984825)
61. Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
Cascinu S; Labianca R; Barone C; Santoro A; Carnaghi C; Cassano A; Beretta GD; Catalano V; Bertetto O; Barni S; Frontini L; Aitini E; Rota S; Torri V; Floriani I; ; Pozzo C; Rimassa L; Mosconi S; Giordani P; Ardizzoia A; Foa P; Rabbi C; Chiara S; Gasparini G; Nardi M; Mansutti M; Arnoldi E; Piazza E; Cortesi E; Pucci F; Silva RR; Sobrero A; Ravaioli A
J Natl Cancer Inst; 2007 Apr; 99(8):601-7. PubMed ID: 17440161
[TBL] [Abstract][Full Text] [Related]
62. Treatment of localized gastric cancer.
Macdonald JS
Semin Oncol; 2004 Aug; 31(4):566-73. PubMed ID: 15297947
[TBL] [Abstract][Full Text] [Related]
63. A phase II trial of 5-fluorouracil, doxorubicin, mitomycin C, and leucovorin in advanced gastric carcinoma.
Arbuck SG; Silk Y; Douglass HO; Nava H; Rustum YM; Milliron S
Cancer; 1990 Jun; 65(11):2442-5. PubMed ID: 2337858
[TBL] [Abstract][Full Text] [Related]
64. Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group.
Van Cutsem E; Van de Velde C; Roth A; Lordick F; Köhne CH; Cascinu S; Aapro M;
Eur J Cancer; 2008 Jan; 44(2):182-94. PubMed ID: 18093827
[TBL] [Abstract][Full Text] [Related]
65. Adjuvant and neoadjuvant approaches in gastric cancer.
Ng K; Meyerhardt JA; Fuchs CS
Cancer J; 2007; 13(3):168-74. PubMed ID: 17620766
[TBL] [Abstract][Full Text] [Related]
66. Evidence based radiation therapy for locally advanced resectable and unresectable gastric cancer.
Koukourakis GV
World J Gastrointest Oncol; 2011 Sep; 3(9):131-6. PubMed ID: 22007277
[TBL] [Abstract][Full Text] [Related]
67. Advances in Systemic Therapy for Gastric Cancer.
Hsu A; Raufi AG
Gastrointest Endosc Clin N Am; 2021 Jul; 31(3):607-623. PubMed ID: 34053641
[TBL] [Abstract][Full Text] [Related]
68. Small cell carcinoma of the stomach: A report of two cases and a review of the literature.
Bakogeorgos M; Kalkanis D; Katsaounis P; Ramfidis V; Speliades C; Pierrakou E; Papadopoulos S; Pantazopoulos N; Georgoulias V; Kotsakis A; Kentepozidis N
Mol Clin Oncol; 2018 Jul; 9(1):11-16. PubMed ID: 29896397
[TBL] [Abstract][Full Text] [Related]
69. Antitumor efficacy of viral therapy using genetically engineered Newcastle disease virus [NDV(F3aa)-GFP] for peritoneally disseminated gastric cancer.
Song KY; Wong J; Gonzalez L; Sheng G; Zamarin D; Fong Y
J Mol Med (Berl); 2010 Jun; 88(6):589-96. PubMed ID: 20393691
[TBL] [Abstract][Full Text] [Related]
70. Salvage gastrectomy following a combination of biweekly paclitaxel and S-1 for stage IV gastric cancer.
Ishigami S; Natsugoe S; Nakajo A; Matsumoto M; Uenosono Y; Arigami T; Setoyama T; Arima H; Uchikado Y; Kita Y; Sasaki K; Aikou T
J Gastrointest Surg; 2008 Aug; 12(8):1370-5. PubMed ID: 18516651
[TBL] [Abstract][Full Text] [Related]
71. S-1 in gastric cancer: a comprehensive review.
Maehara Y
Gastric Cancer; 2003; 6 Suppl 1():2-8. PubMed ID: 12775012
[TBL] [Abstract][Full Text] [Related]
72. New developments in the treatment of gastric carcinoma.
Wilke H; Preusser P; Fink U; Achterrath W; Meyer HJ; Stahl M; Lenaz L; Meyer J; Siewert JR; Geerlings H
Semin Oncol; 1990 Feb; 17(1 Suppl 2):61-70. PubMed ID: 2305269
[TBL] [Abstract][Full Text] [Related]
73. Chemotherapy of gastric cancer.
Schipper DL; Wagener DJ
Anticancer Drugs; 1996 Feb; 7(2):137-49. PubMed ID: 8740718
[TBL] [Abstract][Full Text] [Related]
74. The treatment of advanced gastric cancer.
Wils J
Semin Oncol; 1996 Jun; 23(3):397-406. PubMed ID: 8658224
[TBL] [Abstract][Full Text] [Related]
75. Current strategies in the management of locoregional and metastatic gastric carcinoma.
Ajani JA; Ota DM; Jackson DE
Cancer; 1991 Jan; 67(1 Suppl):260-5. PubMed ID: 1984825
[TBL] [Abstract][Full Text] [Related]
76. Preoperative and postoperative combination chemotherapy for potentially resectable gastric carcinoma.
Ajani JA; Mayer RJ; Ota DM; Steele GD; Evans D; Roh M; Sugarbaker DJ; Dumas P; Gray C; Vena DA
J Natl Cancer Inst; 1993 Nov; 85(22):1839-44. PubMed ID: 8230264
[TBL] [Abstract][Full Text] [Related]
77. FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer.
Kelsen D; Atiq OT; Saltz L; Niedzwiecki D; Ginn D; Chapman D; Heelan R; Lightdale C; Vinciguerra V; Brennan M
J Clin Oncol; 1992 Apr; 10(4):541-8. PubMed ID: 1548519
[TBL] [Abstract][Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
